Tulavi Therapeutics

Tulavi Therapeutics is a privately held company founded in 2018, based in the United States and focused on developing a portfolio of innovative nerve repair products. The company's slogan, "Our innovative in situ technologies are designed to meet the needs of each nerve and expand accessibility to nerve care," reflects its commitment to advancing nerve care accessibility. Tulavi Therapeutics leverages its innovative Adaptive Hydrogel Technology to address the poor and unpredictable outcomes in neuroma prevention, adhesion reduction, and nerve repair. This technology is engineered to support nerve healing, emphasizing the company's dedication to developing solutions that can potentially revolutionize nerve care. With a focus on the biotechnology, health care, life sciences, and medical devices industries, Tulavi Therapeutics aims to make significant contributions to nerve care and treatment. Although specific details about the last investment and investors are not available at present, the company's dedication to innovative nerve repair products positions it as a potentially impactful player in the field of nerve care.